Ferring Pharmaceuticals enjoys a strong reputation within the international gastroenterology community, being able to offer effective medications for the treatment of diseases of the gastrointestinal tract.

Disorders of the gastrointestinal system are widespread. In western societies these problems are a common reason for needing medical treatment. They can account for up to 20 per cent of all visits to family doctors.

Refined diets, food additives, stressful lifestyles, excessive alcohol intake and smoking are common factors contributing to many gastrointestinal problems seen in the West, while in developing areas of the world infections and parasitic infestations can be found to be at the root of many gastrointestinal disorders.

Through a committed research division, Ferring continually strives to improve the treatment of long-term and life threatening gastrointestinal problems. Our research programme has resulted in the development of many effective products.

These products help to improve the quality of life of people suffering from distressing gastroenterology conditions such as inflammatory bowel disease, Ulcerative Colitis and Crohn’s Disease. Our vasoactive product is for bleeding oesophageal varices and, in some markets, hepatorenal syndrome, life threatening diseases. Our dual action laxative medication helps patients who need to undergo gastro-intestinal examinations.